Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13-Reference-Cited by-同舟云学术

Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13

Published:2009-05-07 Issue:11 Volume:52 Page:3523-3538
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Monovich Lauren G.¹,Tommasi Ruben A.¹,Fujimoto Roger A.¹,Blancuzzi Vincent¹,Clark Kirk¹,Cornell Wendy D.¹,Doti Robert¹,Doughty John¹,Fang James¹,Farley David¹,Fitt John¹,Ganu Vishwas¹,Goldberg Ronald¹,Goldstein Robert¹,Lavoie Stacey¹,Kulathila Raviraj¹,Macchia William¹,Parker David T.¹,Melton Richard¹,O’Byrne Elizabeth¹,Pastor Gary¹,Pellas Theodore¹,Quadros Elizabeth¹,Reel Noela¹,Roland Dennis M.¹,Sakane Yumi¹,Singh Hem¹,Skiles Jerry¹,Somers Joseph¹,Toscano Karen¹,Wigg Andrew¹,Zhou Siyuan¹,Zhu Lijuan¹,Shieh Wen-Chung¹,Xue Song¹,McQuire Leslie W.¹

Affiliation:

1. Arthritis and Bone Metabolism Research, Novartis Institutes for BioMedical Research, 100 Technology Square, Cambridge, Massachusetts 02139

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm801394m

Reference66 articles.

1. Understanding the role of tissue degrading enzymes and their inhibitors in development and disease

2. Drug discovery in the extracellular matrix

3. Metalloproteases as potential therapeutic targets in arthritis treatment